Melanesia Experiences in Marine Drug Discovery at University of the South Pacific” Prof. B. Aalbersberg and K.-D. Feussner CDDC, IAS, USP.

Slides:

Advertisements

Similar presentations

1 Increasing Biotech Involvement in Global Health Innovation Oxford Conference on Innovation and Technology Transfer for Global Health September 11, 2007.

Advertisements

David M. Pollock Medical College of Georgia Discovery-Academia.

BIO-PROSPECTING PRUNUS AFRICANA IN UGANDA By David L.N. Hafashimana (Ph.D) National Forestry Resources Research Institute (NaFORRI), UGANDA.

Regional ABS Capacity- Building Workshop for Eastern and Southern Africa, Addis Ababa October 2 nd -6 th, 2005 Bioprospecting for enzymes in protected.

LEGAL AND REGULATORY REGIME FOR ACCESS AND BENEFIT SHARING IN KENYA Presented By: Anne N. Angwenyi National Environment Management Authority (Kenya)

National Herbarium & Botanic Gardens of Malawi

Anti-Malaria Consortium Dr Maureen Wolfson

Access to and Use of Traditional Knowledge A view from industry Bo Hammer Jensen.

Update on the Protected Areas System Master Plan March 2011.

Session 4 - Communities of practice Natural Products Drug Discovery The ICBG Program: A view from afar* Special thanks to Joshua Rosenthal of the NIH Fogarty.

Lecture 7 – NPs and The Pharmaceutical Industry. Artemisinin Artemisinin treats multi-drug resistant strains of malaria. It is a sesquiterpene lactone.

The Convention on Biological Diversity, access to genetic resources and IPR Yovana Reyes Tagle University of Helsinki.

Emerging Challenge? Accessing Genetic Resources : the building blocks of new technologies Access and Benefits Sharing, an emerging issue transitioning.

THE LAW MAKING PROCESS OF AN ACCESS AND BENEFIT SHARING REGIME IN KENYA Presented By: Anne N. Angwenyi National Environment Management Authority (Kenya)

Tissue Banking Marilyn Mason, Ph.D. March 3, 2009.

Tissue Banking Marilyn Mason, Ph.D. January 14, 2009.

Information Exchange in Botanical Garden Networks Royal Botanic Gardens Kew.

The University of Arizona

Access and Benefit Sharing and the Nagoya Protocol Nashina Shariff Manager Environmental Stewardship Branch November 2014.

International Society for Biological & Environmental Repositories An international society for biobanking Founded in members

What do all of these have in common?. Natural Products Drug Discovery Searching for Cures in the Plant Kingdom They all contain natural products…

1 Roles of UNEP, GEF & CBD in the Environment 2 nd Training Workshop for BCH Regional Advisors May 2006 Bangkok, Thailand.

Changes in DNA can produce variation

Home William Ehlers Team Leader, External Affairs GEF Familiarization Seminar Washington, DC November 1 st, 2013 What is the GEF?

The GEF Replenishment How does it come about? Gustavo Fonseca Head, Natural Resources Biodiversity, International Waters, Land Degradation, SFM/REDD+ Global.

Human Genome Project. In 2003 scientists in the Human Genome Project obtained the DNA sequence of the 3 billion base pairs making up the human genome.

Partnering with Federal Labs: A Panel Discussion FLC Mid-Atlantic Region Annual Meeting October 24, 2007.

Perspectives on the Sharing of Research Materials and Data Reid Adler Founder and Principal, Practical Innovation Strategy Washington, DC Presentation.

Biotechnology in Medicine Chapter 12.

Options for governing the microbial commons informed by the need to bridge the 1993 CBD divide Microbial Commons National Academy of Science October 8-9,

Industrial Microorganisms and Product Formation

A new international regime: how does it affect botanic gardens? Kate Davis CBD Unit, Conventions and Policy Section, Royal Botanic Gardens, Kew Eurogard.

Finish up array applications Move on to proteomics Protein microarrays.

Session 4: The Convention on Biological Diversity Making Access Decisions.

Bill Gerwick Research Interests Characterizing the ‘weird and wonderful’ natural products of marine algae and cyanobacteria Drug discovery from marine.

Molecular Techniques in Microbiology These include 9 techniques (1) Standard polymerase chain reaction Kary Mullis invented the PCR in 1983 (USA)Kary.

Marine Biotechnology Introduction Sadia Tahir.  The most recent definition considers marine (or blue) biotechnology as "exploration of the capabilities.

Institutional Structure of the GEF William Ehlers, Head, External Affairs Team American University Seminar April 9, 2012 Washington, DC.

The CBD for Botanists An introduction to the Convention on Biological Diversity for people working with botanical collections.

Samudrala group - overall research areas CASP6 prediction for T Å C α RMSD for all 70 residues CASP6 prediction for T Å C α RMSD for all.

P. Pushpangadan & K. Narayanan Nair National Botanical Research Institute (Council of Scientific & Industrial Research) Lucknow – , India ACCESS.

GENOMIC RESEARCH: INFORMED CONSENT. Genomics- a branch of genetics that sequences DNA to analyze the structure and function of genomes (the complete set.

HUMAN GENOME PROJECT International effort of 13 years (1990 – 2003) Identified all the approximate 20,000 – 25,000 genes in human DNA Determined the sequences.

Secretariat of the Pacific Regional Environment Programme Ninth Global Forum on Bioethics in Research Auckland, New Zealand 3-5 December, 2008 Access &

National Environmental Management: Biodiversity Bill 2003 DEPARTMENT OF ENVIRONMENTAL AFFAIRS AND TOURISM.

GEF Familiarization Seminar January 17 – 19, 2012 Mark Zimsky, Biodiversity Coordinator Senior Biodiversity Specialist, Global Environment Facility GEF-5.

D4FF55A0-6B6F BF422A9BA9 Present by: Xiao Chen On December 7, 2015.

Towards an Integrated Research Policy in the Area of Drug Discovery in the Arab Countries Including mechanisms to better utilization of their terrestrial.

The International Treaty on Plant Genetic Resources for Food and Agriculture and The Convention on Biological Diversity Training Workshop The International.

Bioprospecting Lecture 17. Marine sponges with cancer promise Hundreds of compounds isolated from natural environments are in use or in development for.

Gene Technology Continued. Southern Blotting Using an amplified gene as a probe to identify the same or a similar gene in another sample.

Unit 1 – Living Cells.  The study of the human genome  - involves sequencing DNA nucleotides  - and relating this to gene functions  In 2003, the.

Strathclyde’s natural products and assay facilities SIDR.

The opportunities and challenges of sharing genomics data with the pharmaceutical industry Shahid Hanif, Head of Health Data & Outcomes, ABPI DNA digest.

The role of basic research in antibiotic discovery and development Prof Jeff Errington FMedSci FRS Centre for Bacterial Cell Biology, Newcastle University.

A LEGAL UPDATE By: Ben Hemmelgarn. Introduction  Personal Introduction  Coordination with Governments  Convention on Biological Diversity  Nagoya.

Industrial Microorganisms and Product Formation

Marine Biotechnology Introduction

Sustainable Forest Management

Isolation and purification of marine bioactive compounds

Gene Editing Tools and Methods

Antimicrobial Resistance: Plans for Korea and Beyond

The Inter-American Biodiversity Information Network Progress Summary

Developing Biopesticides from a Researcher’s Perspective

1999 MOSAICC 2001 CBD BONN GUIDELINES

Nagoya Protocol on Access & Benefit Sharing Arising from the Utilization of Biological Resources GEF/UNEP-SPREP Regional Project on the Ratification of.

Introduction/Terminology

Overview of my expertise

Microbial Diversity between Buffalo Creek and a Retention Pond

Module 1: Introduction to the Convention on Biological Diversity

Presentation transcript:

Melanesia Experiences in Marine Drug Discovery at University of the South Pacific” Prof. B. Aalbersberg and K.-D. Feussner CDDC, IAS, USP

Bioprospecting - Background 25-50% of western medicines are derived from natural sources (e.g. aspirin, quinine, many anti- cancer agents and anti biotic drugs) Sales near $800 billion Process takes 15–20 years and costs $800 million 1 in 10,000 chance to develop medicine from given organism

Bioprospecting Process Permitting 2.Collecting 3.Extraction 4.Bioactivity Testing 5.Fractionation and Purification 6.Structure elucidation

Bioprospecting Process Organism Identification and Recollection 8.Structure – Activity Relationships 9.Toxicology Tests 10.Clinical Trials 11.Pray

Microbial Bioprospecting 1.Plating substrate 2.Colony Isolation and Purification 3.Fermentation 4.Extraction of Ferment 5.As in macroorganisms

Genetic Material DNA can be extracted, amplified and sequenced Sections of genome that are responsible for various functions (diseases, chemical production) can be identified

Work at USP 1.Permitting 2.Collecting 3.Extraction 4.Bioactivity Testing 5.Fractionation and Purification 6.Structure elucidation

Types of Samples Organism Extracted chemicals Extracted DNA

Convention on Biological Diversity and Access and Benefit Sharing Prior informed consent Fair agreement on mutually agreed terms Participation and sharing of benefits Environmentally sound uses

Types of Benefits Cash (sample fee and royalties) Help in resource management Voucher specimen Legal review Participation in work and capacity building Sharing results Transfer of technology Access to biotech outcomes

ABS and Fiji 1995 Verata Project Full policy under the Sustainable Development Bill (1997?) Ad-hoc policies of Forestry (terrestrial) and Fisheries (marine) Interest of AG’s office Availability from CBD Secretariat of Model Provisions

USP Marine Collaborations 1980s UC Santa Cruz (Fiji) 1990s Utah University (Fiji and Van.), Strathclyde (Verata project) 2000s Georgia Tech (Fiji), PharmaMar 2010s Georgia Tech, CRRF (USNIH) (SI), 2015 Nagoya Fund (SI)

Bioactivity Screens 1.Antimicrobial (fungi + bacteria – resistant strains) 2.Anti – cancer test brine shrimp cell lines mechanism based 3.Others possible, e.g. malaria, dengue, Alzheimer, TB, anti-ageing

Potential role of CDDC in regional program Repository of collected specimens (Univ Utah, CRRF (NIH), GIT, JIB, GEF) Both, for macrosamples and microbes Bioprospecting partner Annual reports to governments